Please login to the form below
aspirin
This page shows the latest aspirin news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca’s Brilinta reduces rate of secondary stroke
Detailed results from the phase 3 THALES trial also showed that Brilinta, given at a dose of 90mg twice-daily alongside aspirin, significantly reduced the rate of ischaemic stroke by 21%, ... The drug also reduced the risk for severe bleeding events –
Latest news
-
AZ says Brilinta hits the mark in new stroke trial
This time round, AZ evaluated Brilinta (ticagrelor) at a dose of 90-mg twice-daily, taken with aspirin for 30 days, in the phase 3 THALES trial. ... AZ has already tried to prove Brilinta’s benefit over aspirin in preventing stroke, but failed to do so
-
AZ unveils phase 3 Brilinta data in CAD and type 2 diabetes
The study demonstrated that Brilinta plus aspirin reduced the risk of cardiovascular death, heart attack or stroke by 10% compared to aspirin alone.
-
AZ says Brilinta hits the mark in diabetic heart disease
The study showed that in diabetics with CAD and no prior history of heart attack or stroke, Brilinta given on top of aspirin therapy achieved a statistically-significant reduction in a ... Last year, the GLOBAL LEADERS study last year also showed that
-
Xarelto no better than aspirin in secondary stroke study
low-dose aspirin, which is commonly prescribed for this purpose, but failed to hit the mark at the interim stage. ... While bleeding rates were low overall, an increase in bleeding was observed in the rivaroxaban arm compared to the low dose aspirin arm,
-
Xarelto beats aspirin for recurrent blood clots
A new phase III trial shows that Bayer and Janssen's novel oral anticoagulant (NOAC) Xarelto is more effective than aspirin at preventing recurrent blood clots, with no increase in bleeding ... It's already known that after an initial few months of
More from news
Approximately 1 fully matching, plus 71 partially matching documents found.
Latest Intelligence
-
Deal Watch September 2016
Zontivity is a protease-activated receptor-1 antagonist indicated for use in combination with daily aspirin and/or clopidogrel to reduce thrombotic cardiovascular events.
-
Using social data to see patients more clearly
Drugs and databases analysed. The study focused on two drugs, aspirin and Lipitor, that had a relatively high prevalence among the ADR reports in both the clinical and the social media ... To begin with, the two most common reactions to aspirin in both
-
Lonafarnib: promising results in first-ever trial for progeria
Low-dose aspirin is often used for prevention of heart attacks and children have received heart bypass surgery.
-
Country report: The healthcare market in Germany
Pharmaceutical market. With a tradition of invention in the medical field that brought aspirin, Germany has been an attractive pharmaceutical market for years.
-
Country report: The healthcare market in Japan
Under the revised Pharmaceutical Affairs Act, supermarkets and other stores can sell non-prescription drugs, including cold tablets and aspirin.
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest appointments
-
Natasha Giordano joins PLx Pharma
We are confident Natasha will be a driving force for PLx as we transition from the development phase to the commercial launch of our lead product, PL2200 Aspirin.”. ... I look forward to building on the compelling clinical data and initial market
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Modern alternatives to banner exhibition stands (why a reusable pharma exhibition stand could save you money)
Consider things like tasty food, care packages for attendees who are on their feet all day (include power-snacks, blister plasters and aspirin!).
-
Pharma exhibition stand design: size doesn’t have to matter
Consider things like tasty food, care packages for attendees who are on their feet all day (include power-snacks, blister plasters and aspirin!) or a handy phone charger to stand out
-
Introduction to the manufacturing of biologics
There is a significant distinction that needs to be made between traditional small molecule pharmaceuticals (such as aspirin), and biopharmaceuticals.
-
Are we harnessing the full emotional power of brand creativity?
In their 1981 experiment, psychologists Branthwaite and Cooper concluded that branded aspirin tablets were “significantly more effective than unbranded tablets in relieving headaches” accounting for some “one-quarter to one-third”
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- US secures 100 million doses of Sanofi/GSK’s COVID-19 vaccine
- Boehringer/Lilly's Jardiance hits the mark in pivotal heart failure trial
- Roche’s Tecentriq combo scores FDA approval for melanoma
- AstraZeneca escapes pandemic impact as new drugs bolster revenues
- Roche’s Actemra fails in late-stage severe COVID-19 study
- Live Webinar: Examining the Interface Between Healthcare & Society
- Novavax reports promising phase 1 results for coronavirus vaccine
- Merck enters agreement with Hanmi for investigational NASH drug
- AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies
- Virtual Engagement At Porterhouse: Reflections on the past few months
- July 2020: diversity and inclusion in clinical trials round-up
PMHub
Onyx Health Ltd
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...
Latest intelligence
- Virtual Engagement At Porterhouse: Reflections on the past few months
- ...
- July 2020: diversity and inclusion in clinical trials round-up
- COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
- Medical Device Clinical Trials 2020
- In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
Quick links
Infographics
